Objective: We explored two different methods of determining adverse events (AEs) among
methylphenidate (MPH)-treated adolescents with attention-deficit/hyperactivity disorder …

Abstract Background: Methylphenidate (MPH)-related adverse events are well
characterized. Their predictors and their relationship with therapeutic effects are less well …

Objective: There is no questionnaire to specifically monitor perceived adverse events of
methylphenidate (MPH) on cognition, motivation, and mood. The current study therefore had …

Objective: We sought to ascertain whether baseline anxiety/depression and oppositional
defiant disorder (ODD) symptoms impacted the experience of short-term methylphenidate …

Objective: The aim of the current study was to determine various aspects of methylphenidate
adverse reactions in children with attention deficit-hyperactivity disorder (ADHD) in Iran …

Objective The purpose of this study was to examine differences in methylphenidate (MPH)
response between groups of children with attention-deficit hyperactivity disorder (ADHD) …

To compile an inventory of European healthcare databases with potential to study long-term
effects of methylphenidate (MPH) in patients with attention deficit hyperactivity disorder …

Objective The aim of this study was to assess the type and frequency of adverse events
(AEs) in children with attention-deficit/hyperactivity disorder (ADHD) treated with …

Objective: The purpose of this study was to investigate whether the availability of both
dextroamphetamine and methylphenidate provides an opportunity to minimize adverse …

Objective: Our intensive pharmacosurveillance monitoring program was performed to
increase the number of adverse drug reactions (ADRs) recorded in the Italian spontaneous …